stator 40
unipharm ltd, israel - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 40 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction ) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.
minoxi 2
trima israel pharmaceutical products maabarot ltd - minoxidil - solution - minoxidil 2 %w/v - minoxidil - minoxidil - androgenetic alopecia in females.
minoxi 5
trima israel pharmaceutical products maabarot ltd - minoxidil - solution - minoxidil 5 % - minoxidil - minoxidil - androgenetic alopecia in males .
moxypen forte 250 mg powder for suspension
abic marketing ltd, israel - amoxicillin as trihydrate - powder for suspension - amoxicillin as trihydrate 250 mg / 5 ml - amoxicillin - amoxicillin - infections caused by amoxicillin - susceptible organisms and prevention of bacteremia in patients at risk of developing bacterial endocarditis.
topiramate teva 300 mg
teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 300 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children from 2 years and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .
topiramate teva 300 mg
teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 300 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.
topiramate teva 400 mg
teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children from 2 years and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .
topiramate teva 400 mg
teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.
levetrim 250
trima israel pharmaceutical products maabarot ltd - levetiracetam - film coated tablets - levetiracetam 250 mg - levetiracetam - levetiracetam - - levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
levetrim 500
trima israel pharmaceutical products maabarot ltd - levetiracetam - film coated tablets - levetiracetam 500 mg - levetiracetam - levetiracetam - - levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.